Literature DB >> 10820394

Tracing and characterization of the low-avidity self-specific T cell repertoire.

K E de Visser1, T A Cordaro, D Kioussis, J B Haanen, T N Schumacher, A M Kruisbeek.   

Abstract

It is well established that expression of self antigens results in the deletion of the functional high-avidity self-specific T cell repertoire. Due to the low frequency of naturally occurring low-avidity self-specific T cells, a detailed evaluation of their ability to survive and differentiate into effector and memory populations in vivo has yet to be obtained. We here employ tetramer technology to characterize and determine the in vivo fate of a self-specific CD8(+) T cell population specific for a ubiquitously expressed T cell epitope. We find that in influenza nucleoprotein (NP)-transgenic mice (B10NP mice) an oligoclonal population of NP(366 - 374)-specific T cells can be triggered by live influenza virus exposure. The main hallmark of this self-specific T cell population is its diminished avidity for the tetrameric MHC / NP peptide complex. These low-avidity T cells are not deleted and do not down-regulate their antigen or CD8 receptors, and exhibit cytolytic activity towards tumor cells expressing NP endogenously. Strikingly, a secondary influenza infection generates a typical memory response in the low-avidity repertoire. The observation that low-avidity T cells persist in vivo and can differentiate into memory T cells underscores their potential role in anti-tumor immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820394     DOI: 10.1002/(SICI)1521-4141(200005)30:5<1458::AID-IMMU1458>3.0.CO;2-2

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

Review 1.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

2.  Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.

Authors:  R W Tindle; K Herd; T Doan; G Bryson; G R Leggatt; P Lambert; I H Frazer; M Street
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 3.  Recent progress in the analysis of αβT cell and B cell receptor repertoires.

Authors:  Mark M Davis; Scott D Boyd
Journal:  Curr Opin Immunol       Date:  2019-07-18       Impact factor: 7.486

4.  Amplifying TLR-MyD88 signals within tumor-specific T cells enhances antitumor activity to suboptimal levels of weakly immunogenic tumor antigens.

Authors:  Degui Geng; Liqin Zheng; Ratika Srivastava; Cruz Velasco-Gonzalez; Adam Riker; Svetomir N Markovic; Eduardo Davila
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

5.  Identification of Highly Cross-Reactive Mimotopes for a Public T Cell Response in Murine Melanoma.

Authors:  Beth E Grace; Coralie M Backlund; Duncan M Morgan; Byong H Kang; Nishant K Singh; Brooke D Huisman; C Garrett Rappazzo; Kelly D Moynihan; Laura Maiorino; Connor S Dobson; Taeyoon Kyung; Khloe S Gordon; Patrick V Holec; Overbeck C Takou Mbah; Daniel Garafola; Shengwei Wu; J Christopher Love; K Dane Wittrup; Darrell J Irvine; Michael E Birnbaum
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

6.  Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis.

Authors:  Brile Chung; Tor B Stuge; John P Murad; Georg Beilhack; Emily Andersen; Brian D Armstrong; Jeffrey S Weber; Peter P Lee
Journal:  Cell Rep       Date:  2014-07-31       Impact factor: 9.423

7.  Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice.

Authors:  Sanjay Sharma; Ana Lucia Dominguez; Soraya Zorro Manrique; Federica Cavallo; Shimon Sakaguchi; Joseph Lustgarten
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

Review 8.  Mobilizing the low-avidity T cell repertoire to kill tumors.

Authors:  Rachel H McMahan; Jill E Slansky
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

9.  In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.

Authors:  Todd D Schell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Cutting edge: The signals for the generation of T cell memory are qualitatively different depending on TCR ligand strength.

Authors:  Karin M Knudson; Sara E Hamilton; Mark A Daniels; Stephen C Jameson; Emma Teixeiro
Journal:  J Immunol       Date:  2013-11-15       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.